NCT04454151 2020-07-01
FAP
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
Clinical Trials
4 trialsNCT00140894 2019-09-20
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT02354560 2015-02-03
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT02175914 2014-06-26
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown